In a highly unusual move for a normally buttoned-up regulatory agency, a senior official with the US Food and Drug ...

The lesson of the 2016 fight to keep kratom off the DEA’s scheduling list was that federal agencies cannot ignore science and invoke “public health” without evidence. The kneejerk response to ...

Geopolitical jitters continue to weigh on the ASX healthcare sector, even as LTR Pharma advances its erectile dysfunction ...

The role of natural products in drug discovery in India was discussed at the inaugural session of the National Conference on Translational Opportunities in Natural Products Research, organised by the ...

Q4 2025 . Management View. Curran Simpson, President and CEO, stated, "2026 is set to be a pivotal year for REGENXBIO with great focu ...

The Kansas Senate has moved to ban kratom, putting it in the same class as heroin.

To inform clinicians on the best biologic agent for different populations of adults with severe asthma, 12 experts ...

This episode, titled Rethinking KDIGO Guidance and Payer Models in the Era of Targeted IgA Nephropathy Therapies, features expert nephrologists discussing the following critical questions: What ...

A poll published Thursday found that Americans have lost trust in federal health institutions and are more likely to say they trust independent, professional medical organizations when it comes to ...

Meanwhile, prescriptions for an unproven autism treatment soared after a widely watched September press conference by Trump ...

Public confidence that career scientists at federal health agencies such as the Centers for Disease Control and Prevention ...

Americans are losing confidence in the nation’s public health agencies, a new survey finds. RFK Jr. has vowed to restore ...